Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form
  • Home
  • Company News

Company News

Spark Therapeutics announces addition to Board of Directors Spark Therapeutics announces addition to Board of Directors Peli BioThermal hires new VP of Crēdo on Demand Peli BioThermal hires new VP of Crēdo on Demand Peli BioThermal hires new VP of Crēdo on Demand Targovax appoints Chief Business Officer Targovax appoints Chief Business Officer Antabio announces executive appointments Antabio announces executive appointments GW Pharmaceuticals announces appointments to Board of Directors GW Pharmaceuticals announces appointments to Board of Directors Nicox appoints Dr Tomas Navratil Head of Development Nicox appoints Dr Tomas Navratil Head of Development VIVUS announces change in leadership VIVUS announces change in leadership Juniper Pharma Services’ co-founder awarded CBE Juniper Pharma Services’ co-founder awarded CBE Juniper Pharma Services’ co-founder awarded CBE NexOptic appoints Karen Fleming to Board of Directors NexOptic appoints Karen Fleming to Board of Directors Sanifit appoints Chief Medical Officer and President of its US subsidiary Sanifit appoints Chief Medical Officer and President of its US subsidiary Thrombolytic Science announces the appointment of Annalisa Jenkins Thrombolytic Science announces the appointment of Annalisa Jenkins Tim Slomp joins executive board of Uhlmann Tim Slomp joins executive board of Uhlmann Tim Slomp joins executive board of Uhlmann Slomp will succeed Peter Wagner as Managing Director Technology & Development in January 2018 Atlas Genetics expands Executive Team Atlas Genetics expands Executive Team Exscientia appoints Alex Snow as Deputy Chairman Exscientia appoints Alex Snow as Deputy Chairman Exscientia appoints Alex Snow as Deputy Chairman STORM Therapeutics grows Scientific Advisory Board STORM Therapeutics grows Scientific Advisory Board STORM Therapeutics grows Scientific Advisory Board BioGenes establishes Scientific Advisory Board BioGenes establishes Scientific Advisory Board BioGenes establishes Scientific Advisory Board
  • Previous
  • 1
  • …
  • 61
  • 62
  • 63
  • 64 (current)
  • 65
  • 66
  • 67
  • …
  • 213
  • Next

Trending Articles

  1. Hansa Biopharma appoints Fredrik Röök as VP Business Development Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) today announced that Fredrik Röök has been appointed as VP Business Development effective 17th August. Mr Röök will report to CEO Renée Aguiar-Lucander
  2. Entact Bio appoints John G. Houston, Ph.D., to its Board of Directors A veteran biopharma innovator who helped advance the first FDA-approved PROTAC drug, Dr. Houston will strengthen Entact's leadership in induced-proximity therapeutics
  3. Alfa Laval appoints new managing director to drive strategic growth Alessandro Bracco will lead Alfa Laval UK & Ireland as the company targets growth opportunities across key sectors, including pharmaceutical
  4. MHRA scientific leader recognised in 2026 King's Birthday Honours Dr Nicola Rose receives OBE for services to science and public health
  5. Aplagon appoints Carl Lindgren as Board Chair to guide later stage clinical and corporate development Veteran life sciences executive brings over 30 years of strategic and commercial leadership as Aplagon advances through Phase 2 development in multiple thrombosis-inflammatory diseases

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
  • Terms and Conditions
  • Privacy
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK.